Workflow
破发股步长制药跌3.21% 2016年上市募39亿元

Core Viewpoint - The stock of Buchang Pharmaceutical (603858.SH) is currently in a state of decline, with a closing price of 18.67 yuan and a drop of 3.21% [1] Group 1: Company Overview - Buchang Pharmaceutical was listed on the Shanghai Stock Exchange on November 18, 2016, with an issuance of 69.8 million shares at an initial price of 55.88 yuan [1] - The total amount raised from this issuance was 390,042.40 thousand yuan, with a net amount of 367,143.57 thousand yuan after deducting issuance costs [1] Group 2: Fund Utilization - The funds raised are intended for the construction of a cardiovascular drug production base in Shaanxi, as well as for supplementing working capital and repaying bank loans [1] - The total issuance costs for this public offering amounted to 22,898.83 thousand yuan, with the underwriter and sponsor, CITIC Securities, receiving 21,974.80 thousand yuan in fees [1]